Prevalence of hepatitis C virus infection in porphyria cutanea tarda: Systematic review and meta-analysis

Journal of Hepatology

Volumn 39, Issue 4, 2003, Pages 620-627

  Gisbert, Javier P ^a   García Buey, Luisa ^a   Pajares, José María ^a   Moreno Otero, Ricardo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Hepatitis C virus; Meta analysis; Porphyria cutanea tarda; Systematic review

Indexed keywords

BIBLIOGRAPHIC DATABASE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; META ANALYSIS; POLYMERASE CHAIN REACTION; PORPHYRIA CUTANEA TARDA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROLOGY;

EID: 0141674800     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00346-5     Document Type: Article

References (79)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
2. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-1569.
3. Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123:615-620.
4. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002;36:1439-1445.
5. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998;18:67-75.
6. Bonkovsky HL, Barnard GF. The Porphyrias. Curr Treat Options Gastroenterol 2000;3:487-500.
7. de Verneuil H, Aitken G, Nordmann Y. Familial and sporadic porphyria cutanea: two different diseases. Hum Genet 1978;44:145-151.
8. Bonkovsky HL, Mehta S, Hepatitis C:. a review and update. J Am Acad Dermatol 2001;44:159-182.
9. Cohen PR. Porphyria cutanea tarda in human immunodeficiency virus-seropositive men: case report and literature review. J Acquir Immune Defic Syndr 1991;4:1112-1117.
10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. J Am Med Assoc 2000;283:2008-2012.
11. Castanet J, Lacour JP, Bodokh J, Bekri S, Ortonne JP. Porphyria cutanea tarda in association with human immunodeficiency virus infection: it is related to hepatitis C virus infection? Arch Dermatol 1994;130:664-665.
12. O'Connor WJ, Murphy GM, Darby C, Fogarty J, Mulcahy F, O'Moore R, et al. Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol 1996;132:1443-1447.
13. Drobacheff C, Derancourt C, Van Landuyt H, Devred D, de Wazieres B, Cribier B, et al. Porphyria cutanea tarda associated with human immunodeficiency virus infection. Eur J Dermatol 1998;8:492-496.
14. Andreone P, Cursaro C, Gramenzi A, Guidetti MS, Bardazzi F, Tosti A, et al. Detection of hepatitis C virus by polymerase chain reaction and recombinant immunoblot assay 3.0 in porphyria cutanea tarda. Hepatology 1995;21:1754-1755.
15. Antonov K, Krastev Z, Teoharov P, Zaharieva E, Alexiev A, Ivanova A, Hepatitis C, et al. virus infection: a possible promoting agent in porphyria cutanea tarda. Ital J Gastroenterol 1996;28:482-486.
16. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998;27:1661-1669.
17. Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee D J, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000;95:1565-1571.
18. Chuang TY, Brashear R, Lewis C. Porphyria cutanea tarda and hepatitis C virus: a case-control study and meta-analysis of the literature. J Am Acad Dermatol 1999;41:31-36.
19. Cribier B, Petiau P, Keller F, Schmitt C, Vetter D, Heid E, et al. Porphyria cutanea tarda and hepatitis C viral infection. A clinical and virologic study. Arch Dermatol 1995;131:801-804.
20. Cribier B, Petiau P, Stoll-Keller F, Schmitt C, Vetter D, Held E, et al. [Porphyria cutanea tarda and hepatitis C virus infection. Clinical and virological study]. Ann Dermatol Venereol 1996;123:200-202.
21. Dabrowska E, Jablonska-Kaszewska I, Falkiewicz B. High prevalence of hepatitis C virus infection in patients with porphyria cutanea tarda in Poland. Clin Exp Dermatol 1998;23:95-96.
22. Dabrowska E, Jablonska-Kaszewska I, Bielawski KP, Falkiewicz B. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients. Med Sci Monit 2001;7:190-196.
23. Carpintero P, DeCastro M, Garcia-Monzon C, Garcia-Buey L, Borque MJ, Garcia-Diez A, et al. Hepatitis C virus infection detected by viral RNA analysis in porphyria cutanea tarda. J Infect 1997;34:61-64.
24. Dereure O, Aguilar-Martinez P, Bessis D, Perney P, Vallat C, Guillot B, et al. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France. Br J Dermatol 2001;144:533-539.
25. Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig Dis Sci 2002;47:419-426.
26. Fargion S, Piperuo A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992;16:1322-1326.
27. Fargion S, Sergi C, Bissoli F, Fracanzani AL, Suigo E, Carazzone A, et al. Lack of association between porphyria cutanea tarda and alpha 1-antitrypsin deficiency. Eur J Gastroenterol Hepatol 1996;8:387-391.
28. Fernandez-Miranda C, de la Calle M, Gomez Izquierdo MT, Larumbe S, Enriquez de Salamanca R. Serum lipoproteins in patients with porphyria cutanea tarda. Med Clin (Barc) 1999;112:656-657.
29. Ferri C, Baicchi U, la Civita L, Greco F, Longombardo G, Mazzoni A, et al. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 1993;23:851-855.
30. Ferri C, La Civita L, Zignego AL. Extrahepatic manifestations of hepatitis C virus infection. Ann Intern Med 1996;125:344; discussion 346.
31. Fracanzani AL, Taioli E, Sampietro M, Fatta E, Bertelli C, Fiorelli G, et al. Liver cancer risk is increased in patients with porphyria cutanea tarda in comparison to matched control patients with chronic liver disease. J Hepatol 2001;35:498-503.
32. Gibson PR, Ratnaike S, Blake D, Sinickas V. Porphyria cutanea tarda and hepatitis C. Med J Aust 1995;162:54.
33. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993;341:788-789.
34. Hussain I, Hepburn NC, Jones A, O'Rourke K, Hayes PC. The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. Clin Exp Dermatol 1996;21:283-285.
35. Koester G, Feldman J, Bigler C. Hepatitis C in patients with porphyria cutanea tarda. J Am Acad Dermatol 1994;31:1054.
36. Kondo M, Horie Y, Okano J, Kitamura A, Maeda N, Kawasaki H, et al. High prevalence of hepatitis C virus infection in Japanese patients with porphyria cutanea tarda. Hepatology 1997;26:246.
37. Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993;128:121-123.
38. Lamoril J, Andant C, Bogard C, Puy H, Gouya L, Pawlotsky JM, et al. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. Hepatology 1998;27:848-852.
39. Lamoril J, Andant C, Gouya L, Malonova E, Grandchamp B, Martasek P, et al. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT). Cell Mol Biol (Noisy-le-grand) 2002;48:33-41.
40. Lim HW, Harris HR, Fotiades J. Hepatitis C virus infection in patients with porphyria cutanea tarda evaluated in New York. Arch Dermatol 1995;131:849.
41. Lopez Morante A, Saez-Royuela F, Martin Lorente JL, Yuguero del Moral L, Ojeda Gimenez C. Hepatitis C virus infection and porphyria cutanea tarda. Gastroenterol Hepatol 1995;18:7-10.
42. Malina L, Arenberger P, Kracikova J. The frequency of viral hepatitis C in patients with porphyria cutanea tarda. Cas Lek Cesk 1994;133:599-601.
43. Malina L, Stransky J, Havlickova M, Zd'arsky E. Chronic hepatic porphyria and hepatitis B and C virus infections. Cas Lek Cesk 1998;137:561-564.
44. Mancini C, Griso D, Rivanera D, Macri A, Casino C, Lilli D. Porphyria cutanea tarda and hepatitis G and C virus infection. Eur J Clin Microbiol Infect Dis 1998;17:534-535.
45. Martin-Vivaldi Martinez R, Espinosa Aguilar MD, Sanchez Sanchez-Vizcaino J, Quintero Fuentes D, Nogueras Lopez F, Lopez de Hierro Ruiz M. Association of porphyria cutanea tarda and hepatitis C virus. Rev Esp Enferm Dig 1996;88:213-216.
46. Martinelli AL, Zago MA, Roselino AM, Filho AB, Villanova MG, Secaf M, et al. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection. Am J Gastroenterol 2000;95:3516-3521.
47. McCrossin I. Porphyria cutanea tarda in south-east New South Wales. Australas J Dermatol 2002;43:285-288.
48. Moran MJ, Fontanellas A, Brudieux E, Hombrados I, de Ledinghen V, Couzigou P, et al. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Hepatology 1998;27:584-589.
49. Murphy A, Dooley S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. Lancet 1993;341:1534-1535.
50. Nagy Z, Koszo F, Par A, Nagy A, Horanyi M, Morvay M, et al. Are the hemochromatosis (HFE) gene mutation and hepatitis C virus (HCV) infection risk factors for porphyria cutanea tarda? Orv Hetil 2000;141:2031-2034.
51. Navas S, Bosch O, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology 1995;21:279-284.
52. Piperno A, D'Alba R, Roffi L, Pozzi M, Farina A, Vecchi L, Hepatitis C, et al. virus infection in patients with idiopathic hemochromatosis (IH) and porphyria cutanea tarda (PCT). Arch Virol 1992;4:215-216.
53. Quecedo L, Costa J, Enriquez de Salamanca R. Role of hepatitis C virus in porphyria cutanea tarda hepatopathy. Med Clin (Barc) 1996;106:321-324.
54. Rivanera D, Lilli D, Griso D, Macri A, Mancini C. Hepatitis C virus in patients with porphyria cutanea tarda: relationship to HCV-genotypes. New Microbiol 1998;21:329-334.
55. Salmon P, Oakley A, Rademaker M, Duffill M, Hepatitis C. virus infection and porphyria cutanea tarda in Australasia. Arch Dermatol 1996;132:91.
56. Siersema PD, ten Kate FJ, Mulder PG, Wilson JH. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver 1992;12:56-61.
57. Sinclair PR, Gorman N, Shedlofsky SI, Honsinger CP, Sinclair JF, Karagas MR, et al. Ascorbic acid deficiency in porphyria cutanea tarda. J Lab Clin Med 1997;130:197-201.
58. Skowron F, Berard F, Grezard P, Wolf F, Morel Y, Perrot H. Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases. Ann Dermatol Venereol 2001;128:600-604.
59. Stolzel U, Schuppan D, Tillmann HL, Manns MP, Tannapfel A, Doss MO, et al. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study. Cell Mol Biol (Noisy-le-grand) 2002;48:43-47.
60. Stransky J, Malina L, Cieslarova B, Stritesky J, Putova I, Horak J. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda. Acta Virol 2000;44:23-28.
61. Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, et al. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998;28:404-409.
62. Tannapfel A, Stolzel U, Kostler E, Melz S, Richter M, Keim V, et al. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients. Virchows Arch 2001;439:1-5.
63. Tsukazaki N, Watanabe M, Irifune H. Porphyria cutanea tarda and hepatitis C virus infection. Br J Dermatol 1998;138:1015-1017.
64. Wolff C, Armas R, Puig A, Krause P, Parraguez A. Hepatitis C virus infection in patients with porphyria. Rev Med Chil 1994;122:294-298.
65. DeCastro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Buey L, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993;17:551-557.
66. Stolzel U, Kostler E, Koszka C, Stoffler-Meilicke M, Schuppan D, Somasundaram R, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995;21:1500-1503.
67. Malina L, Zdarsky E, Havlickova M, Stransky J. Detection of HCV RNA in anti-HCV positive patients with chronic hepatic porphyria. Cas Lek Cesk 1996;135:427-429.
68. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000;79:47-56.
69. Sampietro M, Fracanzani AL, Corbetta N, Amato M, Mattioli M, Molteni V, et al. High prevalence of hepatitis C virus type lb in Italian patients with Porphyria cutanea tarda. Ital J Gastroenterol Hepatol 1997;29:543-547.
70. Oubina JR, Quarleri JF, Sawicki MA, Mathet VL, Ruiz V, Schroder T, et al. Hepatitis C virus and GBV-C/hepatitis G virus in Argentine patients with porphyria cutanea tarda. Intervirology 2001;44:215-218.
71. Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, et al. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990;12:1295-1299.
72. Siegel LB, Eber BB. Porphyria cutanea tarda remission. Ann Intern Med 1994;121:308-309.
73. Takikawa H, Yamazaki R, Shoji S, Miyake K, Yamanaka M. Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda. J Hepatol 1995;22:249-250.
74. Okano J, Horie Y, Kawasaki H, Kondo M. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. Hepatogastroenterology 1997;44:525-528.
75. Sheikh MY, Wright RA, Burruss JB. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C. Dig Dis Sci 1998;43:529-533.
76. Furuta M, Kaito M, Gabazza E, Fujita N, Ishida S, Tamaki S, et al. Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels. J Gastroenterol 2000;35:60-62.
77. Gibson PR, Grant J, Cronin V, Blake D, Ratnaike S. Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces. J Gastroenterol Hepatol 2000;15:192-201.
78. Jessner W, Der-Petrossian M, Christiansen L, Maier H, Steindl-Munda P, Gangi A, et al. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C. Hepatology 2002;36:1301-1302.
79. Flamm S, Chopra S. Porphyria cutanea tarda and hepatitis C vires infection. UpToDate 2002;10:1-4.